Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor

scientific article published on 01 December 2017

Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/ACSOMEGA.7B01031
P932PMC publication ID6045391
P698PubMed publication ID30023586

P2093author name stringYuan Yuan
Ran Wang
Chuan Li
Menglong Li
Tao Liang
Xuemei Pu
Yanzhi Guo
P2860cites workStructure of a nanobody-stabilized active state of the β(2) adrenoceptorQ24597139
Structure and function of an irreversible agonist-β(2) adrenoceptor complexQ24620291
Crystal structure of the β2 adrenergic receptor-Gs protein complexQ24635327
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observationsQ24645752
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptorQ24657484
A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic ReceptorQ27650801
Crystal structure of opsin in its G-protein-interacting conformationQ27652301
Conserved Binding Mode of Human β 2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray CrystallographyQ27663654
VMD: visual molecular dynamicsQ27860554
PubChem Substance and Compound databasesQ27942588
Dynamics of folded proteinsQ28287584
Recommendations for evaluation of computational methodsQ28755020
The meaning and use of the area under a receiver operating characteristic (ROC) curveQ29547182
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculationsQ29547632
Development and testing of a general amber force fieldQ29547642
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityQ29547658
ZINC: a free tool to discover chemistry for biologyQ29615857
Exploring the mechanism of F282L mutation-caused constitutive activity of GPCR by a computational studyQ30394046
Pathway and mechanism of drug binding to G-protein-coupled receptors.Q30503489
Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamicsQ30544125
Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer.Q33825866
Putative active states of a prototypic g-protein-coupled receptor from biased molecular dynamics.Q33858599
Ligand-dependent activation and deactivation of the human adenosine A(2A) receptor.Q33998174
Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian ClusteringQ34045014
The conformational transition pathways of ATP-binding cassette transporter BtuCD revealed by targeted molecular dynamics simulationQ34137778
Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.Q34222925
Structural insights into µ-opioid receptor activationQ34488374
Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activationQ34804778
Conformational transition pathway in the allosteric process of human glucokinaseQ35037241
Virtual fragment screening on GPCRs: a case study on dopamine D3 and histamine H4 receptors.Q35114298
Activation mechanism of the β2-adrenergic receptorQ35558683
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor SignalingQ35638953
Pharmacological chaperone action on G-protein-coupled receptors.Q35879860
Analysis and elimination of a bias in targeted molecular dynamics simulations of conformational transitions: application to calmodulinQ36120569
Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical LibrariesQ36235361
Conformational changes in the G protein Gs induced by the β2 adrenergic receptorQ36252945
Structural basis for selectivity and diversity in angiotensin II receptorsQ36335687
Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulationQ36357733
GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools updateQ36454245
Molecular dynamics: survey of methods for simulating the activity of proteinsQ36472758
Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activationQ36481447
The dynamic process of β(2)-adrenergic receptor activationQ36651876
Activation and dynamic network of the M2 muscarinic receptorQ36990877
How to do an evaluation: pitfalls and trapsQ37064087
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complexQ37200963
Catecholamine binding to the beta-adrenergic receptorQ37581625
Progress in structure based drug design for G protein-coupled receptorsQ37880053
Unifying family A GPCR theories of activationQ38190328
An Efficient Metadynamics-Based Protocol To Model the Binding Affinity and the Transition State Ensemble of G-Protein-Coupled Receptor LigandsQ38814799
GPCR Dynamics: Structures in MotionQ38953232
Allosteric coupling from G protein to the agonist-binding pocket in GPCRsQ39643038
Basic principles of ROC analysisQ39680201
Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor.Q41866579
Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptorsQ42110736
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarkingQ42251037
Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.Q43126562
Class I phospho-inositide-3-kinases (PI3Ks) isoform-specific inhibition study by the combination of docking and molecular dynamics simulationQ43238017
Lessons from 60 years of pharmaceutical innovationQ43447062
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.Q50470980
Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.Q51036228
Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay.Q51823232
Understanding the conformation transition in the activation pathway of β2 adrenergic receptor via a targeted molecular dynamics simulation.Q53665507
The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.Q54781021
Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case StudyQ56991400
Ligand induced change of β2adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analysQ57275094
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor LigandsQ57838214
Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics SimulationsQ58195321
Targeted molecular dynamics: a new approach for searching pathways of conformational transitionsQ72696166
Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activationQ79527348
A negative cooperativity mechanism of human CYP2E1 inferred from molecular dynamics simulations and free energy calculationsQ82475640
Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathwayQ85277884
A coupling of homology modeling with multiple molecular dynamics simulation for identifying representative conformation of GPCR structures: a case study on human bombesin receptor subtype-3Q87384614
P433issue12
P304page(s)8557-8567
P577publication date2017-12-01
P1433published inACS OmegaQ27727647
P1476titleStructural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor
P478volume2

Reverse relations

Q91583484Probing the Druggablility on the Interface of the Protein-Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimercites workP2860

Search more.